In addition to altered receptor localization, TrkB.T1 is not only elevated in human gliomas, but also in murine gliomas driven by multiple genetic mechanisms, and across human and rodent GSC and tumorsphere lines (Supplementary Figs. 2 and 7). This evidence concerns the gene NTRK2 and central nervous system cancer.